Piperacillin/tazobactam: extended infusion "good alternative"

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1571, 2007-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of piperacillin-tazobactam

By Hayashi Yoshiro   Roberts Jason A   Paterson David L   Lipman Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1017-1031

Informa Healthcare

Access to resources Recommend Favorite

Piperacillin/tazobactam: Myelosuppression: case report

By  

Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Piperacillin/tazobactam: Thrombocytopenia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. : 31-32

Adis International

Access to resources Recommend Favorite

Caution issued for use of generic piperacillin/tazobactam.

By  

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Piperacillin/tazobactam: Toxic epidermal necrolysis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. : 38-38

Adis International

Access to resources Recommend Favorite